The tumor metabolome
- PMID: 12820363
The tumor metabolome
Abstract
The tumor metabolome is characterized by high glycolytic and glutaminolytic capacities, high phosphometabolite levels and a high channelling of glucose carbons to synthetic processes. This allows tumor cells to proliferate under strong variations in oxygen and glucose supply (http://www.metabolic-database.com). One key regulator of the tumor metabolome is the glycolytic isoenzyme pyruvate kinase type M2 (M2-PK) that is generally over-expressed in all tumor cells. M2-PK can occur in a highly active tetrameric form and in a nearly inactive dimeric form. In tumor cells the dimeric form of M2-PK always predominates and has therefore been termed tumor M2-PK. The dimerization of M2-PK is caused by direct interaction of M2-PK with certain oncoproteins. When M2-PK is in its dimeric state energy is produced by glutaminolysis. The metabolic Achilles' heel of the tumor metabolome is its sensitivity to a reduction of NAD levels caused by activation of poly(ADP-ribose) polymerase after DNA damage.
Similar articles
-
Pyruvate kinase type M2: a crossroad in the tumor metabolome.Br J Nutr. 2002 Jan;87 Suppl 1:S23-9. Br J Nutr. 2002. PMID: 11895152 Review.
-
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.Int J Biochem Cell Biol. 2011 Jul;43(7):969-80. doi: 10.1016/j.biocel.2010.02.005. Epub 2010 Feb 13. Int J Biochem Cell Biol. 2011. PMID: 20156581 Review.
-
Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7.Oncogene. 2001 Oct 18;20(47):6891-8. doi: 10.1038/sj.onc.1204792. Oncogene. 2001. PMID: 11687968
-
Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.Exp Cell Res. 2009 Oct 1;315(16):2765-74. doi: 10.1016/j.yexcr.2009.06.024. Epub 2009 Jun 27. Exp Cell Res. 2009. PMID: 19563799
-
Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.Crit Rev Oncog. 1992;3(1-2):91-115. Crit Rev Oncog. 1992. PMID: 1532331 Review.
Cited by
-
Comparison of the amino acid profile between the nontumor and tumor regions in patients with lung cancer.Am J Cancer Res. 2020 Jul 1;10(7):2145-2159. eCollection 2020. Am J Cancer Res. 2020. PMID: 32775007 Free PMC article.
-
Proteomic Analysis Reveals Distinct Metabolic Differences Between Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Macrophage Colony Stimulating Factor (M-CSF) Grown Macrophages Derived from Murine Bone Marrow Cells.Mol Cell Proteomics. 2015 Oct;14(10):2722-32. doi: 10.1074/mcp.M115.048744. Epub 2015 Jul 30. Mol Cell Proteomics. 2015. PMID: 26229149 Free PMC article.
-
Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression.Oncogene. 2015 Oct;34(43):5482-93. doi: 10.1038/onc.2015.6. Epub 2015 Feb 23. Oncogene. 2015. PMID: 25703326
-
Stable isotope-resolved metabolomics and applications for drug development.Pharmacol Ther. 2012 Mar;133(3):366-91. doi: 10.1016/j.pharmthera.2011.12.007. Epub 2011 Dec 23. Pharmacol Ther. 2012. PMID: 22212615 Free PMC article. Review.
-
Complete absence of M2-pyruvate kinase expression in benign pancreatic ductal epithelium and pancreaticobiliary and duodenal neoplasia.BMC Cancer. 2009 Sep 15;9:327. doi: 10.1186/1471-2407-9-327. BMC Cancer. 2009. PMID: 19754967 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources